Dyspnea Review for the Palliative Care Professional: Treatment Goals and Therapeutic Options

被引:62
|
作者
Kamal, Arif H. [1 ]
Maguire, Jennifer M. [2 ]
Wheeler, Jane L. [1 ]
Currow, David C. [3 ]
Abernethy, Amy P. [1 ,3 ]
机构
[1] Duke Univ, Med Ctr, Div Med Oncol, Dept Med, Durham, NC 27710 USA
[2] Univ N Carolina, Dept Med, Div Pulm Dis & Crit Care Med, Chapel Hill, NC USA
[3] Flinders Univ S Australia, Div Med, Dept Palliat & Support Serv, Bedford Pk, SA 5042, Australia
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; EMPHYSEMA TREATMENT TRIAL; VOLUME-REDUCTION SURGERY; TRANSMUCOSAL FENTANYL CITRATE; PLACEBO-CONTROLLED CROSSOVER; ILL CANCER-PATIENTS; NEBULIZED FUROSEMIDE; OXYGEN-THERAPY; DOUBLE-BLIND;
D O I
10.1089/jpm.2011.0110
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Although dyspnea is frequently encountered in the palliative care setting, its optimal management remains uncertain. Clinical approaches begin with accurate assessment, as delineated in part one of this two-part series. Comprehensive dyspnea assessment, which encompasses the physical, emotional, social, and spiritual aspects of this complex symptom, guide the clinician in choosing therapeutic approaches herein presented as part two. Global management of dyspnea is appropriate both as complementary to disease-targeted treatments that target the underlying etiology, and as the sole focus when the symptom has become intractable, disease is maximally treated, and goals of care shift to comfort and quality of life. In this setting, current evidence supports the use of oral or parenteral opioids as the mainstay of dyspnea management, and of inhaled furosemide and anxiolytics as adjuncts. Nonpharmacologic interventions such as acupuncture and pulmonary rehabilitation have potential effectiveness, although further research is needed, and use of a simple fan warrants consideration given its potential benefit and minimal burden and cost.
引用
收藏
页码:106 / 114
页数:9
相关论文
共 50 条